Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 10 Issue 2, April 2016

Volume 10 Issue 2

MedTech Dealmakers

• Advanced sequencing technologies facilitate precision medicine

• Dealing in diagnostics

• Drug delivery: Hunting for innovative technologies

• Can digital health reshape disease management?

Cover image: Multi-coloured DNA sequence. Wavebreakmedia Ltd, Thinkstock

Precision medicine

    Feature

  • Profiles

  • Advertisement Feature |

    The Antibody Lab is focused on improving screening for preeclampsia during pregnancy and is seeking strategic partners to change the current risk-assessment paradigm.

  • Advertisement Feature |

    Coyote Biosciences has developed a range of miniaturized, portable and battery-powered molecular diagnostics instruments that provide point-of-care testing solutions—from detecting infectious diseases to profiling cancer—for health care providers and patients globally.

Dealing in diagnostics

Drug delivery

Digital health

    Feature

  • News Feature |

    After a slow arrival, digital advances in health care are now progressing rapidly. Boosted by a $4.5 billion investment in 2015, the digital health market is now seeing the development of a wave of wearable and mobile technologies to monitor, control and collect data on many of today’s diseases.

    • Nick Taylor

Search

Quick links